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Abstract
Disruption of cell cycle regulation is one mechanism proposed for how nuclear envelope protein mutation can cause
disease. Thus far only a few nuclear envelope proteins have been tested/found to affect cell cycle progression: to identify
others, 39 novel nuclear envelope transmembrane proteins were screened for their ability to alter flow cytometry cell cycle/
DNA content profiles when exogenously expressed. Eight had notable effects with seven increasing and one decreasing the
4N:2N ratio. We subsequently focused on NET4/Tmem53 that lost its effects in p53
2/2 cells and retinoblastoma protein-
deficient cells. NET4/TMEM53 knockdown by siRNA altered flow cytometry cell cycle/DNA content profiles in a similar way as
overexpression. NET4/TMEM53 knockdown did not affect total retinoblastoma protein levels, unlike nuclear envelope-
associated proteins Lamin A and LAP2a. However, a decrease in phosphorylated retinoblastoma protein was observed
along with a doubling of p53 levels and a 7-fold increase in p21. Consequently cells withdrew from the cell cycle, which was
confirmed in MRC5 cells by a drop in the percentage of cells expressing Ki-67 antigen and an increase in the number of cells
stained for ß-galactosidase. The ß-galactosidase upregulation suggests that cells become prematurely senescent. Finally, the
changes in retinoblastoma protein, p53, and p21 resulting from loss of NET4/Tmem53 were dependent upon active p38
MAP kinase. The finding that roughly a fifth of nuclear envelope transmembrane proteins screened yielded alterations in
flow cytometry cell cycle/DNA content profiles suggests a much greater influence of the nuclear envelope on the cell cycle
than is widely held.
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Introduction
Several proteins of the nuclear envelope are linked to human
diseases ranging from muscular dystrophies to neuropathy, bone
diseases, and progeroid aging syndromes [1,2]. These proteins
include the intermediate filament A/C Lamins and several
proteins integral to the nuclear membrane. Favored molecular
mechanisms to explain how mutations in nuclear envelope
proteins produce pathology include loss of nuclear mechanical
stability, alterations in gene expression, and cell cycle/stem cell
maintenance defects (reviewed in [2,3,4]). However, the known
functions of the proteins mutated in disease are insufficient to fully
explain the pathologies observed without assistance from partner
proteins that thus far have not been identified.
The first indication of a link between nuclear envelope diseases
and the cell cycle came from studies with specific mutations in the
nuclear envelope transmembrane protein (NET) Emerin linked to
Emery-Dreifuss muscular dystrophy. It was reported that two
disease-linked mutations prolonged S-phase from 12 h to 22 h
when overexpressed in COS-7 cells [5]; however similar effects
were not observed in all disease mutants and so this was not
investigated in further detail. In C. elegans disruption of Emerin
alone did not have a strong effect on the cell cycle, but when
combined with disruption of a second NET, MAN1, it did [6].
Loss of Emerin has also been reported to interfere with
retinoblastoma protein (pRb)-regulated genes in mouse and
consequently with myogenic differentiation [7], and the same
pRb-dependent cell cycle exit is disrupted in nuclear envelope-
linked muscular dystrophy [8]. pRb is a tumor suppressor that
regulates the cell cycle at the G1/S transition by regulating the
E2F family of transcription factors (reviewed in [9]). pRb also
interacts with Lamin A [10], but this is thought to principally
involve the nucleoplasmic and not the nuclear envelope pool of
Lamin A because it operates in a complex with LAP2a, a soluble
splice variant of the nuclear envelope protein LAP2 that is
principally found in the nucleoplasm [11,12,13].
To determine if any of several newly identified nuclear envelope
proteins play a role in the cell cycle, 39 novel confirmed NETs
were screened for their ability to alter flow cytometry cell cycle/
DNA content profiles when exogenously expressed. These NETs
PLoS ONE | www.plosone.org 1 April 2011 | Volume 6 | Issue 4 | e18762were identified in two recent proteomic analyses of liver and blood
cells [14,15]. Seven of the NETs tested showed an increase in the
4N:2N ratio while one showed a decrease. To determine if
pathways affected by these NETs involved the p53 master cell
cycle regulator, these eight NETs were retested in p53
2/2 cells.
The change in 4N:2N ratios still occurred in the absence of p53 for
most NETs, but the effect of NET4/Tmem53 and NET59/Ncln
was lost. NET4/Tmem53 was selected for a more detailed analysis
of how it interacts with the p53 pathway. Knockdown of NET4/
TMEM53 resulted in cell cycle withdrawal, apparently through
activation of the p38 kinase with consequent upregulation of p53
and p21 and downregulation of phosphorylated pRb.
Results
A screen for NETs that alter flow cytometry profiles
To identify nuclear envelope proteins that might contribute to
cell cycle progression, a collection of 39 NETs were screened for
their ability to affect flow cytometry cell cycle/DNA content
profiles. All NETs were fused to a monomeric red fluorescent
protein (mRFP) tag at their carboxyl-termini and were previously
confirmed to target to the nuclear envelope [14,15,16]. HEK293T
human embryonic kidney cells were used for the screen because
this cell line is efficiently transfected, easily recovered from plates
for the flow cytometry experiments, and has a relatively stable
karyotype compared to other commonly used lines such as HeLa,
U2OS or HT1080 cells. Tagged NETs were transiently
transfected into the HEK293T cells and after 40–48 h of
expression the frequency of live cells with 2N or 4N DNA content
was measured by flow cytometry.
DNA profiles were acquired for both the transfected cells
(mRFP positive) and the untransfected population for each
transfection. Thus the use of transient transfections provided an
internal control for each experiment that removed any cell cycle
variation between plates and/or due to the transfection reagent.
For each NET at least three independent flow cytometry
experiments were performed, each on different days and with a
minimum of 1,000 singlet transfected cells (and in most cases
.5,000 cells) analyzed. For those NETs where a strong effect was
observed, additional repeats were done with 20,000 transfected
cells analyzed to increase confidence.
Examples of flow cytometry cell cycle/DNA content profiles are
shown in Figure 1 with the untransfected cell traces (blue) overlaid
with those of the mRFP-expressing population (red). Cell
fragments and apoptosing cells were excluded based on propidium
iodide (PI) staining and FSC/SSC (from light scattering). The flow
cytometry profiles for the mRFP control and many other NETs
tested were indistinguishable from those of untransfected cells in
the same population or only exhibited minor differences. By
contrast, NET11/Sccpdh, NET31/Tmem209, NET59/Ncln,
Tmub1, Fam3c, Magt1 and Tmem126a all yielded striking
accumulations of cells with a 4N DNA content suggesting an
increased G2/M population (Figure 1). NET4/Tmem53 yielded a
different effect, exhibiting a reduction in cells with 4N DNA
content suggestive of more cells in the G1 phase of the cell cycle.
The percentages of cells in G1, S, and G2/M phases based on
DNA content are listed in Table 1. While effects of these eight
NETs were the most striking and reproducible, one cannot
discount that some NETs that caused minor changes might also be
relevant to the cell cycle.
It is possible that some NETs positive in the screen could have
altered flow cytometry DNA content profiles because of aberrant
nuclear morphologies as opposed to effects on cell cycle
progression (though this could in turn reflect problems with
cytokinesis). To test if this was a likely explanation, cells from the
transfected populations were imaged by fluorescence microscopy.
Representative images revealed no gross aberration in nuclear
morphology within the transfected population, indicating this is
unlikely to have affected the flow cytometry results (Figure 2).
Nuclear envelope targeting is not always extremely clear in the
HEK293T cells either because NETs have multiple localizations
or because the high expression saturates binding sites at the
nuclear envelope in these cells; however, all NETs tested here
were previously confirmed to target to the nuclear envelope
[14,15,16].
Some NETs depend on p53 and/or pRb for their effects
The cell cycle protein p53 is often referred to as a master
regulator because it has a role in a large number of cell cycle
pathways. The ability of the eight NETs identified in the initial
screen to alter the flow cytometry DNA content profiles was re-
examinedintheHCT116p53
2/2cellline.ThecontrolsmRFPand
NET51/C14orf1 had not yielded changes in the flow cytometry
DNA content profile in the HEK293T cells and similarly yielded no
significant changes in the p53
2/2 cells (Figure 3A). Correspond-
ingly, NET11/Sccpdh, NET31/Tmem209, Tmub1, Fam3c,
Magt1, and Tmem126a that had exhibited increases in the 4N
population in the HEK293T cells yielded similar changes in the
p53
2/2 cells; so p53 does not appear to be involved in the potential
effects of these NETs on the cell cycle. By contrast, in the p53
2/2
cells NET59/Ncln no longer exhibited a 4N increase and NET4/
Tmem53 no longer exhibited a 4N decrease as had been observed
in the HEK293T cells. Thus changes in the flow cytometry profiles
from expression of NET59/Ncln and NET4/Tmem53 appear to
be p53 dependent. To better compare the results in the p53 positive
and negativecells, the 4N:2Nratios from both cell lines wereplotted
for this set of NETs (Figure 3B). For NETs other than the two that
lost their effects a similar pattern was observed between the two cell
lines, although in some cases the 4N:2N ratio increase was slightly
higher in the HCT116 p53
2/2 cell line. NET4/Tmem53, a
previously uncharacterized protein with no known functional
domains, was subsequently followed in more detail.
Cell cycle effects dependent on p53 often involve changes in
pRb [17] and links have previously been identified between pRb
and nuclear envelope-associated proteins [10,11,12,13]. To
determine if pRb also plays a role in the NET4/Tmem53-directed
effects, flow cytometry cell cycle/DNA content profiles were
determined for cells expressing NET4/Tmem53 or controls in
HEK293T cells with normal or reduced levels of pRb, using
siRNA oligos to knock down pRb. The reduction in the 4N:2N
ratio caused by NET4/Tmem53 was lost in the pRb-depleted cells
(Figure 4A). As pRb phosphorylation is crucial for its role in cell
cycle progression [18,19,20], antibodies to a form of pRb
phosphorylated at serine 780 were utilized to test if phosphory-
lated pRb levels were affected in the NET4/Tmem53 transfected
cells. Because of low and variable transfection efficiencies this
could not be assayed at a population level; thus transfected cells
were stained with the antibodies and the levels of the phosphor-
ylated pRb in the nucleoplasm were quantified by measuring the
average pixel intensity (Figure 4B). Plotting these values revealed a
significant loss of phosphorylated pRb in cells expressing NET4/
Tmem53.
RNAi knockdown of NET4/Tmem53
Further study of the pathways through which NET4/Tmem53
affects cell cycle regulation would not be practical using exogenous
expression because transfection efficiencies were too low (5–10%)
to be able to quantify changes in pathway components by Western
NET Flow Cytometry Screen
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were tested by immunocytochemistry, but proved inadequate for
quantification due both to a diffuse distribution throughout the cell
body and cell-to-cell variation in intensities that appears to result
from induction of stress pathways in some cells during transfection
(data not shown). Therefore, to further elucidate the pathways
through which NET4/Tmem53 affects the cell cycle, its
knockdown was attempted.
Figure 1. Changes in flow cytometry cell cycle profiles for cells overexpressing NETs. HEK293T cells expressing mRFP-NET fusions were
recovered by trypsinization and analyzed by flow cytometry at 48 h post-transfection. Data were analyzed using FlowJo software and histogram
overlays are displayed as %Max, scaling each curve to mode=100%. The red line is the mRFP expressing cells in the population while the blue line is
the untransfected cells in the population (the majority of cells were not transfected). The transfected and untransfected populations were both set on
the scale to 100 for the 2N population so that increases or decreases in the 4N peak reveal changes in the cell distribution. Arrows indicate significant
changes in cell cycle profile between transfected and non-transfected cells.
doi:10.1371/journal.pone.0018762.g001
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TMEM53 (Figure 5A). To determine whether it would be better to
design siRNA oligos to knock down one or both (the original
screen used the shorter variant), long and short splice variants of
NET4/TMEM53 with the GFP moiety at either terminus were
cloned and then tested to determine if both could produce the flow
cytometry cell cycle/DNA content ratio effect of the original
mRFP construct. All constructs yielded the same effect (Figure 5B).
Multiple siRNA oligos were then generated that should knock
down both long and short splice variants. Although the HEK293T
cells were ideal for the flow cytometry-based screen due to their
generally high transfection efficiencies and comparatively stable
DNA content, for subsequent more directed cell cycle experiments
MRC5 primary fibroblasts [21] and the U2OS osteosarcoma cell
line were used because they have comparatively more operational
checkpoint machinery. Moreover, the primary fibroblasts can
enter a state of senescence that is not possible for HEK293T cells.
Before proceeding, the ability of NET4/Tmem53-mRFP expres-
sion to alter flow cytometry DNA content profiles was evaluated in
both MRC5 primary fibroblasts and the U2OS cells, confirming
that a comparable effect to that observed in HEK293T cells
occurred in the MRC5 and U2OS cells (Figure 5C).
Two siRNA oligos (si1 and si2) that should each in theory knock
down both long and short splice variants (Figure 6A) effectively
knocked down NET4/TMEM53 transcripts in MRC5 cells
(Figure 6B). The si2 was slightly more effective than the si1 and
therefore initially used in preference, though all relevant findings
were subsequently verified with both oligos. As NET4/TMEM53 is
an uncharacterized gene with no direct evidence for its full range
of splicing possibilities, it is possible that additional splice variants
exist that the two siRNA oligos do not knock down. Therefore, an
esiRNA that should knock down any and all possible splice
variants of NET4/Tmem53 was also tested and found to be
effective in reducing NET4/TMEM53 transcripts in MRC5 cells
(Figure 6B). Knockdown of NET4/TMEM53 transcripts was also
successful in U2OS cells (Figure 6C).
Available NET4/Tmem53 antibodies could not be used to
determine if the NET4/Tmem53 protein was also being knocked
down because they recognized several closely migrating bands
where NET4/Tmem53 protein is expected to migrate on Western
blot. Nonetheless, the endogenous protein is very likely to be
reduced because cells expressing NET4/Tmem53-GFP prior to
addition of siRNA oligos for NET4/TMEM53 knockdown
exhibited a loss of the fusion protein with both GFP and
NET4/Tmem53 antibodies (Figure 6D and data not shown).
This indirect approach typically indicates knockdown of the
endogenous protein [22].
The effect of NET4/TMEM53 knockdown on flow cytometry
cell cycle/DNA content profiles was next determined. An increase
was observed in the population of cells with a 2N amount of DNA
that was similar to the increase resulting from exogenous NET4/
Tmem53 expression (Tables 1 and 2). A corresponding reduction
was observed in the population of cells with 4N DNA content both
with the knockdown and with overexpression. Both MRC5 and
U2OS cell lines were subsequently used in parallel for most
experiments to ascertain if any observed effects required the more
reliable cell cycle checkpoints of primary cells (MRC5) and thus
were not recapitulated in transformed cell lines such as the U2OS
Table 1. Percentage of cells in each cell cycle phase by flow
cytometry upon exogenous expression of NET-mRFP fusions.
NET mRFP negative mRFP positive
% G1 % S % G2/M % G1 % S % G2/M
untransfected 60 14 21 - - -
mRFP 61 14 20 62 13 20
NET4/Tmem53 62 14 20 74 8 14
NET11/Sccpdh 60 14 20 37 18 38
NET31/Tmem209 58 15 21 39 15 38
NET51/C14orf1 62 16 18 60 17 19
NET59/Ncln 59 15 22 37 19 35
Fam3c 62 10 18 44 10 30
Magt1 65 12 19 53 14 26
Tmub1 63 13 19 50 14 31
Tmem126a 65 13 14 53 17 26
doi:10.1371/journal.pone.0018762.t001
Figure 2. The changes in flow cytometry profile of cells expressing NETs are not caused by aberrant nuclear morphology of cells.
Images of HEK293T cells expressing NET-mRFP shows nuclear morphology depicted by DAPI staining (upper panel) compared to mRFP signal (lower
panel) indicating cells expressing NETs.
doi:10.1371/journal.pone.0018762.g002
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defective for p16INK [23,24].
NET4/TMEM53 knockdown causes premature senescence
in primary fibroblasts but only a cell cycle delay in the
transformed U2OS cells
When MRC-5 cells were transfected with siRNA oligos or
esiRNA for NET4/TMEM53 the number of cells per dish
appeared to be lower than in cultures transfected with the
scrambled control siRNA oligo, yet there did not seem to be an
increase in apoptotic cells. In order to establish the cause of this
difference, cell proliferation was assessed using antibodies to the
nuclear protein Ki-67 that is present only in proliferating cells
[25,26]. In cells knocked down for NET4/TMEM53 (Figure 7A,
upper graph) there was a notable decrease in the frequency of Ki-
67 positive cells from 57.6% in the control scrambled oligo
transfected cells to 26.9% for the NET4/TMEM53 si2 transfected
cells and 10.9% for the NET4/TMEM53 si1 transfected cells.
The esiRNA also confirmed the phenotype (39.6% Ki-67 positive
cells), further indicating its specificity to the NET4/Tmem53
knockdown.
The marked reduction in cell proliferation upon NET4/
TMEM53 knockdown could indicate a permanent arrest or a
temporary arrest from which cells could subsequently recover. ß-
Figure 3. Cell cycle effects of NET4/Tmem53 and NET59/Ncln
depend on p53. (A) Flow cytometry profiles of cells expressing NET-
mRFP fusions in HCT116 p532/2 cells. Most NETs that had produced
increases in the 4N population in Figure 1 yielded similar increases in
the 4N population in HCT116 p532/2 cells; however, NET4/Tmem53
and NET59/Ncln lost their effects. (B) The percentage of cells in the 4N
and 2N populations were calculated and 4N:2N ratios were plotted from
at least three separate experiments with standard errors shown. The
results for the HEK293T cells are shown above those for the HCT116
p532/2 cells.
doi:10.1371/journal.pone.0018762.g003
Figure 4. pRb is also involved in NET4/Tmem53 effects. (A) pRb
was knocked down by siRNA in HEK293T cells subsequently transfected
with NETs. Cell cycle profiles are shown for these cells expressing NET4/
Tmem53 or controls of mRFP alone or NET51/C14orf1 that had no effect
in the original flow cytometry screen. The 2N accumulation effect of
NET4/Tmem53 on the cell cycle profile observed in HEK293T cells was
lost when pRb levels were reduced. The knockdown of pRb is confirmed
in the lower left corner. (B) Photomicrographs of cells overexpressing
the RFP alone control or NET4/Tmem53. Cells were stained with an
antibody that recognizes pRb phosphorylated on serine 780. NET/mRFP
signal is shown in the left panels to identify transfected cells and
phospho-pRb staining in the right panels. In each panel two adjacent
cells are marked by arrowheads, one transfected and the other not
transfected. All micrographs were taken at the same exposure time. The
graph on the right shows quantification of the pixel intensity for the
phospho-pRb staining. The pixel intensity for untransfected controls
internal to each micrograph was set to 1 and average relative values
from 40 transfected cells and 40 untransfected cells for each
transfection are shown with standard errors.
doi:10.1371/journal.pone.0018762.g004
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[27], was therefore assessed in MRC5 primary fibroblasts knocked
down for NET4/TMEM53. At 72 h post transfection, the
percentage of ß-galactosidase positive cells was ,3 times higher
in cell cultures transfected with NET4/TMEM53 siRNA oligos or
esiRNA as compared to untransfected cultures or those transfected
with the control scramble oligo (Figure 7A, lower graph). This
suggests a tendency of NET4/Tmem53 deficient MRC-5 cells to
withdraw from the cell cycle due to premature senescence, which
is a programmed cell response to many extra- and intracellular
stresses with features similar to proliferative senescence and
leading to permanent cell cycle exit.
By contrast, when NET4/TMEM53 siRNA oligo si2 was
transfected into the transformed osteosarcoma U2OS cell line no
decrease of Ki-67 expression or increase of ß-galactosidase was
detected (data not shown), indicating that these cells do not fully
exit the cell cycle. This difference is likely due to the absence in
U2OS cells of p16INK, as this kinase has been reported to be
important for establishment of senescence [23,24]. Confirming
these reports, transcript levels of p16INK were undetectable in
Figure 5. Splice variants of NET4/TMEM53 and the effect of
knockdown in U2OS and MRC5 cells. (A) Two splice variants of
NET4/TMEM53 were cloned that differed only by a 33 amino acid
insertion roughly a third of the way into the protein. (B) Both long (l) and
short (s) splice variants had the same effect on cell cycle/DNA content
profiles andeffects were independent of whether theGFPtag was onthe
amino terminus or carboxyl terminus. (C) Because siRNAs failed to knock
down NET4/TMEM53 in HEK293T cells, the cell cycle/DNA content profile
effect of the original NET4/TMEM53-mRFP construct was tested on U2OS
and MRC5 cells as alternatives for knockdowns.
doi:10.1371/journal.pone.0018762.g005
Figure 6. Knockdown of NET4/TMEM53 in U2OS and MRC5
cells. (A) Splice variants and position of knockdown oligos. (B) NET4/
TMEM53 transcript levels were effectively knocked down in MRC5 cells
using both siRNA oligos and an esiRNA. Peptidylprolyl isomerase A
(PPIA) was used as a control for normalization. (C) NET4/TMEM53
transcript levels were also knocked down in the U2OS cell line using the
siRNA oligo TMEM53 si2. The scramble siRNA oligo had no effect. PPIA
was used as a control for normalization. (D) Western blot demonstrating
the knockdown of NET4/Tmem53. Because antibodies to NET4/Tmem53
recognized multiple bands on Western blot at the expected molecular
weight, knockdown of the protein was tested using a NET4/Tmem53-
GFP fusion and GFP antibodies. The siRNAs were transfected 24 h after
transfection of NET4/Tmem53-GFP in order to enable protein to be
generated from the plasmid prior to the beginning of knockdown.
doi:10.1371/journal.pone.0018762.g006
Table 2. Percentage of cells in each cell cycle phase by flow
cytometry for knockdown of NET4/TMEM53 and controls in
U2OS cells.
%G1 %S %G2/M
untransfected 58 10 32
scramble 59 11 30
oligo si 2 65 12 22
doi:10.1371/journal.pone.0018762.t002
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(Figure 7B). Knockdown of NET4/TMEM53 resulted in a small
increase in p16INK transcript levels (Figure 7B), consistent with
the hypothesis that its absence in U2OS cells underlies the failure
to become senescent. Despite the inability to senesce, some effects
on the cell cycle still occurred in U2OS cells knocked down for
NET4/TMEM53 as BrdU incorporation was reduced by nearly
50% (data not shown), indicating that the frequency of cells in S
phase was greatly reduced. This could indicate that these cells
spend an extended period in G1, consistent with the flow
cytometry data.
NET4/TMEM53 knockdown results in alteration of levels
of several cell cycle regulators
To further understand the pathways mediating the effect of
NET4/Tmem53 on the cell cycle, levels of various cell cycle
regulators before and after NET4/Tmem53 depletion were
quantified by Western blot. In both MRC5 and U2OS cells the
p53 protein level was increased ,2-fold upon loss of NET4/
Tmem53 while p21 levels increased ,7-fold (Figure 8A,B). Total
levels of pRb remained relatively unchanged, but pRb became
hypophosphorylated when NET4/Tmem53 was knocked down
and phosphorylated p38MAP kinase levels increased (Figure 8A,B).
It should be noted that although total pRb levels were unchanged
on average over several experiments with NET4/TMEM53
knockdown, there was reasonable variability in the levels of total
pRb among experiments. Thus the ratio of phosphorylated pRb to
total pRb was likely also somewhat variable, but levels of the
phosphorylated pRb were notably reduced in all experiments. To
confirm that the effect observed was specific for NET4/TMEM53
knockdown the experiment was repeated using oligos si1, si2, and
the esiRNA. The same result was observed with p53 and p21
increasing upon loss of NET4/Tmem53 (Figure 8C).
By contrast no changes were observed in levels for other NE
proteins previously shown to contribute to cell cycle regulation
Emerin, LAP2 (both soluble and transmembrane splice variants
alpha and beta), or Lamin A (Figure 9A). Neither were differences
observed in cyclins A, C, D, or E (Figure 9A,B). Cyclin B levels
may have been slightly reduced; however, considerable variability
was observed between all experiments and so no clear conclusion
could be drawn (data not shown).
NET4/Tmem53 effects on cell cycle protein levels are
mediated by the p38MAP kinase
The p38MAP kinase that was upregulated by NET4/TMEM53
knockdown mediates cell response to range of stresses, such as UV
irradiation, osmotic shock, heat shock, starvation and cytokines
[28]. p38 phosphorylates and stabilizes p53, which activates
transcription of the cdk inhibitor p21 that subsequently blocks the
cell cycle [17]. As this study has shown that p21 is also upregulated
by NET4/TMEM53 knockdown, it seemed likely that the effects
on cell cycle proteins p53, pRb and p21 are mediated by the
p38MAP kinase.
To further test if the increases in p53 and p21 were dependent
on p38MAP kinase, a specific p38 inhibitor SB203580 (Calbio-
Figure 7. NET4/TMEM53 knockdown results in cell cycle
withdrawal. (A) NET4/TMEM53 knockdown with both siRNAs and
the esiRNA all resulted in a reduced number of actively proliferating
cells as measured by Ki-67 staining (upper graph) and an increase in
senescent cells as measured by ß-galactosidase staining (lower graph).
The results from three separate experiments with standard errors are
shown. (B) Differences between MRC5 and U2OS cells in NET4/Tmem53-
induced senescence are likely due to the absence of p16INK in U2OS
cells. RT-PCR was used to detect transcript levels of p16INK. In U2OS
cells no transcripts were observed while in senescent MRC5 cells
transcript levels were greatly increased compared to cycling untrans-
fected MRC5 cells. Knockdown of NET4/Tmem53 also induced p16INK
expression in MRC5 cells, albeit less so than by full senescence.
doi:10.1371/journal.pone.0018762.g007
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siRNA oligos. The cells were harvested 48 h later and levels of
p53, p21, and phosphorylated p38 measured by Western blot. In
all cases the increases resulting from knockdown of NET4/
TMEM53 were lost when p38MAP kinase was inhibited
(Figure 10A,B). Moreover, the NET4/TMEM53 knockdown-
mediated decrease in Ki-67 positive cells was partially abrogated
and the increase in ß-galactosidase staining cells was completely
abrogated (Figure 10C,D). Thus, p38MAP kinase appears to be
activated by NET4/TMEM53 knockdown and mediates most of
the NET4/Tmem53 effects on the cell cycle.
Figure 8. NET4/TMEM53 knockdown alters levels of several cell
cycle proteins. Protein lysates were recovered from both MRC5 and
U2OS cells that were either untransfected, transfected with a scrambled
siRNA, or transfected with the NET4/TMEM53 si2 oligo. (A) Western blots
reacted with antibodies to pRb phosphorylated on serine 780, total pRb,
p53, phosphorylated p38MAP kinase, p21, and actin as a loading control.
Note that some variation in total pRb levels was observed between
experiments, causing the ratio of phosphorylated pRb to total pRb to be
also somewhat variable. Because the phosphorylated form migrates
slightly differently on SDS-PAGE the change in the spread of the band
gives a greater appearance of such variability than is actually measured
upon quantification. (B) Quantification of levels of each protein
normalized to actin using a LI-COR Odyssey and fluorescent secondary
antibodies. Averages from three experiments are shown with standard
errors. (C) To ensure that results reflected effects of NET4/TMEM53
knockdown and not off-target effects both siRNA oligos and the esiRNA
were tested for effects on p53 and p21 levels. Similar results were
observed with all NET4/TMEM53 knockdowns.
doi:10.1371/journal.pone.0018762.g008
Figure 9. NET4/TMEM53 knockdown did not affect levels of
other nuclear envelope proteins linked to the cell cycle or
cyclins. (A) Protein lysates were recovered from U2OS cells treated as
in Figure 8 and reacted on Western blots with antibodies to the various
proteins. This experiment was repeated 3 times and a representative
Western blot is shown. (B) Cyclin levels were quantified from three
separate experiments analyzed by LI-COR using fluorescent secondary
antibodies and are plotted normalized to the actin control. Standard
errors are shown.
doi:10.1371/journal.pone.0018762.g009
NET Flow Cytometry Screen
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This flow cytometry-based screen identified several NETs with
likely cell cycle functions. These NETs are generally uncharacter-
ized proteins, many of which have conserved domains of unknown
function. However, NET59/Ncln has separately been linked to a
pathway that could intersect with cell cycle regulation: this NET
interacts with Nomo1 that binds Smad proteins and thus intersects
with TGFß signaling pathways [29]. The NET MAN1 has also
been found to interact with Smad proteins [30,31] while the NET
Emerin interacts with ß-catenin [32] and disruption of these two
NETs yields cell cycle defects [6]. Thus, combined signaling/cell
cycle effects appear to be a common trait among NETs and it is
likely that further analysis of the other NETs identified in this
screen will yield some similar intersections of nuclear envelope
proteins with cell cycle pathways. That these 8 NETs represent
roughly 20% of the proteins tested in the flow cytometry cell
cycle/DNA content screen and that several recent studies have
found NETs associated with centrosomes or the mitotic spindle
[33,34,35] suggest that a great many nuclear envelope proteins
will be found to contribute to cell cycle regulation.
Here, additionally, NET4/Tmem53 has been demonstrated to
influence cell cycle regulation, affecting maintenance of the
proliferative state of cells. Although the mechanism by which
NET4/Tmem53 expression levels activate p38MAP kinase has
thus far been elusive, it is clear that the effect of NET4/Tmem53
on proliferation is through p38MAP kinase-dependent upregula-
tion of p53 and p21 with subsequent reduction in levels of
phosphorylated pRb. Thus unlike Lamin A and LAP2a that
exert effects directly on pRb to influence cell proliferation
[11,12,13], NET4/Tmem53 acts upstream through stress signal-
ing pathways.
NET4/Tmem53 was originally identified in a proteomic
analysis of liver nuclear envelopes [14] and high-resolution
microscopy on tagged exogenously expressed protein suggests
that it resides in the outer nuclear membrane [16]. Antibodies
generated to NET4/Tmem53 were previously shown to princi-
pally stain the nuclear periphery in liver tissue cryosections and
nuclear envelope versus microsomal fractions isolated from
rodent liver [16]; however, despite reactivity on tissue sections,
these antibodies recognize several additional bands at the
expected molecular weight of NET4/Tmem53 in cultured cells
and so could not be exploited in the current study. The indication
of NET4/Tmem53 as an outer nuclear membrane protein is not
inconsistent with NE functions on the cell cycle. For example,
Emerin, originally thought to reside only in the inner nuclear
membrane [36], affects signaling pathways and has recently
been shown to function also in the outer nuclear membrane and
ER [37].
A potential functional relevance for NET4/Tmem53-induced
cell cycle regulation is suggested by observations that NET4/
TMEM53 is highly expressed in liver cells and adipocytes
according to the BioGPS transcriptome database [38,39]. Recent
studies have shown that the differentiation of mesenchymal stem
cells (MSCs) is influenced by mechanical strain. In response to the
application of physical strain MSCs are prevented from
differentiating along an adipogenic lineage and instead are
redirected towards an osteoblast lineage [40], This gives rise to
the possibility the physical stress provides a homeostatic
mechanism for mesenchymal lineage selection. Since it has
already been shown the NE plays a key role in propagating stress
signaling and sensing [41], it is important to understand which
NE proteins interact with stress signaling pathways and how they
might influence stem cell self renewal and differentiation. We
believe that our data suggests that NET4/Tmem53 has such a
role. Future studies will focus on putative regulation of adipogenic
stem cells by NET4 and its possible involvement in Lamino-
pathies such as Dunnigan-type familial partial lipodystrophy
(FPLD; [42,43]) or mandibuloacral dysplasia (MADA; [44]).
Methods
Plasmid construction
NET expressing plasmids were generated from IMAGE clones
as previously described [14,15,16]. All were under regulation of
the CMV promoter with their carboxyl-termini fused to
monomeric red fluorescent protein (mRFP).
Cell culture and transient transfection
HEK293T (from ATCC; [45]), U2OS (from ATCC; [24]),
MRC5 (from the EUACC; [21]) and HCT116 p53
2/2 (kind gift
of B. Vogelstein, Johns Hopkins University; [46]) cells were
maintained in high glucose DMEM (Invitrogen) supplemented
Figure 10. p38MAP kinase mediates the NET4/Tmem53 effects
on cell cycle proteins. MRC5 and U2OS cells transfected with either
siRNA oligos or controls were treated 24 h after transfection with a
specific inhibitor of the p38MAP kinase. (A) Protein lysates were
generated after a further 48 h and analyzed by Western blot for levels
of p53, phosphorylated p38, and p21. This experiment was repeated 3
times and a representative Western blot is shown. (B) Levels of p53, p21
and phosphorylated p38 were quantified from three separate
experiments analyzed by LI-COR using fluorescent secondary antibodies
and are plotted normalized to the actin control with standard errors. In
all cases the p38MAP kinase inhibitor blocked the effects of NET4/
TMEM53 knockdown on levels of these cell cycle proteins. (C) The
change in the percentage of Ki-67 positive cells induced by NET4/
TMEM53 knockdown is partially abrogated by blocking the function of
p38 kinase. (D) Effects of NET4/TMEM53 knockdown on senescence, as
determined by ß-galactosidase staining, are abrogated by blocking
p38MAP kinase function.
doi:10.1371/journal.pone.0018762.g010
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streptomycin sulfate (Invitrogen). For U2OS siRNA assays cells
were seeded at 30% confluency and the next day transfected
using Dharmafect transfection reagent 1 according to the
manufacturer recommendations (Dharmacon RNA Technolo-
gies). MRC5 cells were trypsinized at ,80% confluency and
3610
6 cells were aliquoted for nucleofection using Kit R,
Program V-020 (Lonza). The cells were transfected with either
8 mg of siRNA oligo or 12 mg of esiRNA (esiRNA human
TMEM53, Sigma) and plated to 10 cm dishes with several
coverslips. At 48 or 72 h coverslips were removed and fixed for
immunocytochemistry and the remaining cells on the plate were
harvested by trypsinization and lysed in sample buffer for SDS-
PAGE and Western blotting. Alternatively they were lysed in
Trizol reagent (Sigma) for isolation of RNA. HEK293T cells
were either nucleofected using Kit V Program Q-001 (Lonza) or
were transfected using Fugene 6 or HD (Roche). For microscopy,
cells were generally plated on coverslips in 24 well dishes after
nucleofection or were first plated and then transfected using
Fugene. In this case, plating was at ,10% confluency so that cells
did not reach confluency before 30 h post-transfection when they
were fixed. Then, roughly 12 h after plating, DNA was
transfected using Fugene. For p38MAP kinase inhibitor exper-
iments the specific inhibitor SB203580 (Calbiochem) was added
to cultures at 10 mM concentration 12 h after transfection with
siRNA oligos.
Cell cycle assay
Plasmids encoding different NETs fused to mRFP were
transfected into HEK293T cells using Fugene 6 transfection
reagent (Roche). At 48 h post-transfection, the DNA stain Hoechst
33342 (Molecular Probes) was added to the cells at a final
concentration of 5 mg/ml and left to incubate at 37uC for a period
of 30 min to 60 min. Cells were harvested by trypsinization,
trypsin was inactivated with serum and cell pellets were collected
by centrifugation at 2506g for 5 min at RT, washed once in PBS
and resuspended in 1 ml of PBS. Cells were immediately analyzed
on an LSR II flow cytometer (BD Bioscience, UK) equipped with
488 nm and 350 nm lasers and appropriate filters. Cells with
fragmented DNA that might be undergoing necrosis or apoptosis
and cell aggregates were excluded from analysis by application of
electronic gates. Cell cycle analysis was carried out on the live
singlets gate using FlowJo software (TreeStar, Inc). At least 10,000
cells were scored for the total live singlets and 1,000 cells for the
mRFP positive live singlets. Each experiment was repeated at least
2 times for negative results and 3 times for those with a positive
effect on the cell cycle. For further confirmation NETs that
showed an effect on the cell cycle in 3 independent experiments
(NET4/Tmem53, NET11/Sccpdh, NET31/Tmem209, NET59/
Ncln, Tmub1, Fam3c, Magt1 and Tmem126a) were repeated a
4
th time where at least 20,000 mRFP positive intact singlets were
counted. Data are displayed in the form of histogram overlays
using %Max option, which scales each population curve to
mode=100%.
Antibodies
Antibodies to the following proteins were used: Ki-67 (610968,
BD Transduction Lab), total Rb (4H1 9309, Cell signaling),
phospho-Rb (9307, Cell Signaling), p21 (556430, BD Transduc-
tion lab), p53 rabbit (9282, Cell signaling), p53 mouse (NCL-p53-
DO1, Leica), p38 total (9212, Cell Signaling), active p38 (V3281
Anti-active MAPK Family Sampler, Promega), cyclin E mAb
clone HE12 (32-1600, Invitrogen), cyclin A mAb clone Cy-A1
(4710, Sigma), cyclin D (2922, Cell Signaling), cyclin B (SC245,
Santa Cruz), LAP2ß (06-1002, Millipore), Lap2a previously
described in [47], Lamin A and B1 (3262 and 3931) previously
described in [48]. All fluorophore-conjugated secondary antibod-
ies used for immunofluorescence were minimally cross-reactive
from donkey (Jackson ImmunoResearch) or goat (Molecular
Probes). For Western blotting IR800 conjugated goat anti-rabbit
antibodies (LI-COR Biosciences) were used.
Immunofluorescence microscopy
Cells transfected with NETs were fixed for 7 min in 3.7%
formaldehyde, permeabilized for 6 min in 0.1% Triton X-100,
blocked with 3% BSA in PBS, and reacted for 40 min at RT with
antibodies to Ki-67 or phospho-Rb. After washing, appropriate
fluorophore-conjugated secondary antibodies were added for
30 min at RT and washed. Cells were also stained with Hoechst
33342 (Molecular Probes) to visualize nuclei and mounted in
fluoromount G (EM Sciences). For ß-galactosidase assays,
histochemical staining at pH 6.0 was performed as described in
[27].
Images were obtained using a Nikon TE-2000 microscope
equipped with a 1.45 NA 1006 objective, Sedat quad filter set,
PIFOC Z-axis focus drive (Physik Instruments), and CoolSnapHQ
High Speed Monochrome CCD camera (Photometrics) run by
IPLab image acquisition software. Micrographs were saved from
source programs as .tif files and prepared for figures using
Photoshop 8.0.
Quantification of grey levels for NETs was performed using .tif
images from IPLab imported into Image Pro Plus. Cells fixed and
stained with phosho-Rb antibodies were imaged using identical
settings. Average grey scale values (pixel) intensity were measured
for at least 40 mRFP positive cells and as many untransfected cells
on the same coverslips.
Quantitative Western blotting
Cells were scraped and lysed in 50 mM Tris-HCl (pH 7.4),
150 mM NaCl, 2 mM MgCl2, 0.2% NP-40 in the presence of
protease inhibitor cocktail (Roche 11 873 580 001) by heating at
65uC for 2 min and sonication in a sonibath at 4uC. Protein
concentrations were determined using the Bradford Method
(BioRad). An equal volume of protein sample buffer (100 mM
Tris pH 6.8, 4 M Urea, 2% SDS, 50 mM DTT and 15% sucrose)
was added and the samples were boiled at 100uC for 5 min then
sonicated in a sonibath with high frequency for 10 min with 30 sec
interval on/off. Equal amounts of protein were resolved by SDS-
PAGE and transferred to Nitrocellulose membrane (LI-COR
Biosciences). Membranes were blocked in PBS, 5% milk, 0.2%
tween-20. Primary antibodies were diluted in this buffer and
allowed to incubate overnight at 4uC. Secondary antibodies IR800
conjugated goat anti-rabbit (LI-COR Biosciences) were added at
concentration 1/5000 at RT for 2 h. Visualization and quantifi-
cation were performed using a LI-COR Odyssey and software
(Odyssey 3.0.16) using median background subtraction. A
minimum of three independent blots was run for each NET and
control. The averages from all three are presented in figures with
standard error shown.
siRNA oligos
NET4/TMEM53 oligo si1: 59-AGAAGUGGGUGUGGAA-
GAGGG-39. NET4/TMEM53 oligo si2: 59- UAGUAAGUAGG-
GUAGUCACGG-39. Scramble control oligo 59-UCGAAGU-
AUUCCGCGUACG-39. Sigma NET4/TMEM53 esiRNA EH-
U027971.
pRb siRNA oligo: GCCCUUACAAGUUUCCUAG [49].
NET Flow Cytometry Screen
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Cells were lysed on tissue culture plates with Tri-Reagent
(Sigma), and total RNA was extracted according to the
manufacturers instructions. RT-PCR reactions were carried out
with 100 ng of total RNA using the Titan one tube RT-PCR
system (Roche) in accordance with the manufacturer’s instruc-
tions, except that the dNTP concentration was increased to
500 mM and MgCl2 increased to 3 mM. Typical reaction
conditions were 30 min reverse transcription at 50uC, 2 min
denaturation at 94uC, then 24 cycles of 94uC for 30 s, 60uC for
30 s and 68uC for 45 s. Peptidylprolyl isomerase A (PPIA) was
used as a loading control and reactions were repeated at least three
times.
The human primer sets used were: NET4/TMEM53 59-
AAGCTGCTCGAGCTGCTC3-39 and 59-CAGAGGCTTGT-
GTAGTAA-39; PPIA 59-CACCGTGTTCTTCGACATTG-39
and 59-TCGAGTTGTCCACAGTCAGC-39.
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